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Background: Chronic obstructive pulmonary disease (COPD) is a common disease worldwide
with significant morbidity and mortality.
Aim: To investigate the effect of a comprehensive COPD management programme in
decreasing COPD readmissions 1 year before and 1 year after the programme.
Method: 185 (166 males) patients admitted for acute exacerbation of COPD (AECOPD) were re-
cruited between September 2010 and December 2012. COPD care team provided crisis support
and maintenance therapy for the COPD patients for a total of 16 weeks. The protocol included
COPD clinic run by respiratory physicians, COPD education and nurse clinics by respiratory
nurses, out-patient pulmonary rehabilitation programme by physiotherapists, fast track doc-
tor’s clinic, telephone hotline for patients and nurse telephone calls to patients. Readmissions
over a period of 1 year were assessed.
Results: The mean (SD) age of the subjects and FEV1 % predicted normal were 76.9  7.37 yrs
and 44.4  20.7% respectively. 40 (21.6%) patients required non-invasive positive pressure
ventilation during the recruitment admission. Admissions for AECOPD decreased from
2.39  2.05 one year before programme to 1.65  2.1 one year after programme (mean differ-
ence 0.75  2.11 episodes, p < 0.001). The length of hospital stay was reduced from
12.17  9.14 days one year before programme to 9.09  12.1 days one year after the pro-
gramme (mean difference 3.09  12.1 days, p < 0.001). The FEV1 percentage predicted and
quality of life measured by St George’s Respiratory Questionnaire showed no significant
improvement at 16 weeks after recruitment into the programme as compared to at 6 weeks.
Conclusion: COPD care programme is effective in decreasing readmissions and length of hospi-
tal day for COPD patients.
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COPD is a common disease worldwide [1,2] with significant
morbidity and it incurs heavy utilization of healthcare re-
sources. The prevalence of COPD varied from 11.4 to 26.1%
in a multi-city population study with spirometry [1]. In
2005, COPD ranked second as a respiratory cause for hos-
pitalization and inpatient bed days in Hong Kong. Among
those >75 years of age, hospitalization rate for acute
exacerbation of COPD (AECOPD) was as high as 2225/
100,000 [3]. The prevalence of moderate COPD, using the
spirometric reference of FEV1/FVC ratio of <70%, among
1008 elderly HK Chinese (age 60 years) in the community,
were 19.6% and 11.9% in the male and female subjects
respectively [4].
Efforts have been made to test various integrated pro-
grammes for the COPD patients in an attempt to improve
their quality of life and reduce hospital readmissions in
various countries. These interventions include disease
specific self-management plans [5,6], implementation of
the chronic care model [7], integrated model with multi-
disciplinary input [8] and home visits by respiratory health
workers [9e11], with mixed success. A recent study even
found that a comprehensive care management programme
could not decrease COPD-related hospitalizations and the
trial was terminated prematurely due to the unanticipated
excess mortality in the active arm [12]. It is thus importantFigure 1 Workflow of theto explore other COPD programme for its efficacy and
safety.
The target group of this study consisted of severe COPD
patients who required hospitalization for management of
their exacerbation (about 1/5 of our subjects were using
home oxygen therapy at baseline and 1/5 required non-
invasive positive ventilation (NPPV) support during hospital
admission). We aimed to assess if the comprehensive care
programme would confer benefit to this group of “severe
COPD patients” by decreasing their readmissions for
AECOPD.
Methods
We assessed the readmissions and length of hospital stay for
AECOPD for our patients 1 year before and 1 year after the
programme. The quality of life, lung function and exercise
capacities of the patient were also assessed at 6 weeks and
16 weeks post discharge from the hospital. This was basi-
cally an audit of our service programme by comparing
changes involving the subjects before and after the pro-
gramme and there was thus no control group. There is no
need for ethical committee approval for clinical audit in
our institution. All patients who joined our programme had
given verbal consent for their clinical data to be used for
auditing purposes. The programme commenced in
September 2010 and we included the subjects who had firstCOPD care programme.
Table 1 Demographic data of the subjects (n Z 185).
Male/female 166 male/
19female
Age (years) 76.9  7.37
Smoking history
Current smoker 34 (18.3)
Ex-smoker 144 (77.8)
Non-smoker 7 (3.8)
Post-bronchodilator FEV1 (L) 0.86  0.39
FVC (L) 1.73  0.63
FEV1 % predicted
normal
44.4  20.7
FVC % predicted
normal
63.6  21.5
FEV1/FVC ratio (%) 49.6  13.4
FEV1% predicted
normal
80% 11 (5.9)
50e79% 55 (29.7)
30e49% 68 (36.8)
<30% 51 (27.6)
6 min walk test
(meters)
194  131
BMI (kg/m2) 21.02  4.15
MMRC 2.5  1.01
Baseline
medications
Inhaled SABA 166 (89.7%)
Inhaled LAMA 18 (9.7%)
Inhaled LABA 94 (50.8%)
ICS 159 (85.9%)
Theophylline 44 (23.8%)
Number of COPD exacerbations in the
previous 12 months
2.39  2.05
On home oxygen therapy 38 (20.5%)
Need for NIV in the recruitment admission 40 (21.6%)
Data are presented as mean  SD or n (%).
SABA Z short acting beta agonist, LAMA Z long acting musca-
rinic agent, LABA Z long acting beta agonist, ICS Z inhaled
steroid.
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2012 in this audit.
Patients who were hospitalized for AECOPD at the Prince
of Wales Hospital, a tertiary teaching hospital affiliated
with the Chinese University of Hong Kong with 1500 beds,
were recruited into this programme. AECOPD was defined
as a patient with background COPD who presented with at
least two of the following major symptoms (increased
dyspnoea, increased sputum purulence, increased sputum
volume) or one major and one minor symptom (nasal
discharge/congestion, wheeze, sore throat, cough) for at
least two consecutive days. Exclusion criteria included
patients who have terminal malignancy or serious major
organ disease (e.g. severe renal failure not offering renal
replacement therapy, severe liver disease and intractable
heart failure) with limited expected survival.
Our programme consisted of input from a COPD care
team, including respiratory physicians, respiratory nurses,
physiotherapists and community nurses (CS), who provided
crisis support and maintenance therapy for up to 16 weeks
for the COPD patients. Due to the limited resources, we
only enrolled up to 2 patients per day on weekdays. Pa-
tients were identified by the respiratory nurse in the
medical wards and invited to join our programme. The
nurse would explain the nature of the programme
and obtain permission for using his/her data to assess the
effectiveness of the programme. The protocol included
designated COPD clinic run by respiratory physicians, COPD
education and nurse clinics managed by respiratory nurses,
out-patient pulmonary rehabilitation programme by phys-
iotherapists, fast track doctor’s clinic, telephone hotline
(patient could talk to respiratory nurse directly during of-
fice hours. After office hours, calls were recorded and
returned as soon as possible in the next working day) and
other post-discharge support (CS visits and out-patient
physiotherapist training) (Fig. 1).
The COPD education sessions were conducted in the
nurse clinics on a one to one basis (total 2 sessions, first
session lasted for 45 min to 1 h and second session lasted
for 30e45 min). The patients were provided with general
knowledge of COPD (the causes, simple pathology,
symptoms and treatment) and their inhaler techniques
were checked and errors corrected. In addition, the res-
piratory nurses made telephone calls to patients at week
4, 8, 12 and 14 following hospital discharge to discuss with
the patients over their COPD management and offer
advice or fast tract clinics (doctor/nurse clinic) as
appropriate. In addition, patients were offered out-
patient physiotherapy training sessions (up to 3 times a
week for 3 months, each session 1 h). If patients were
reluctant to return for these sessions, training on home
exercise would be provided.
Patients also attended the doctor’s clinic on week 6 and
week 16 post discharge, where the medical therapy of their
COPD was optimized according to guidelines [13] and co-
morbid illnesses managed by the respiratory physician. At
the doctor’s visit, the height and weight of the subjects
were measured. In addition, spirometry pre and post-
bronchodilator and 6 min walk test [14] were performed.
Subjects also completed the St George’s Respiratory
Questionnaire (SGRQ) [15] for assessment of quality of life
and the modified Medical Research Council (mMRC)questionnaire [16] for assessment of subjective feeling of
dyspnoea. Data of the hospital admissions (including the
number of admissions and length of stay) before recruit-
ment into the programme were charted by both reviewing
the record and cross-checking with the patient during the
first visit to the doctor’s clinic. Their subsequent hospital
admissions and mortality after the index admission were
recorded up to a period of 12 months. The information was
collected at the doctor’s clinic at 16 weeks and patients
were also contacted by phone and also their hospital re-
cords were checked at 12 months.
We have estimated the sample size needed to decrease
0.5 episode of readmission after the programme. Based on
previous study [17] on integrated care on prevention of
readmissions (with 0.9  1.3 vs 1.3  1.7 readmissions in
the following year in the intervention versus the usual care
group), a sample size of 122 was needed for a statistically
significant effect of 0.5 episode reduction in readmissions
over a year period by accepting an alpha risk of 0.05 and a
beta risk of 0.15 in a two-sided test.
Analysis was conducted using Statistical Package for the
Social Sciences Version 21.0 (IBM Corporation, NewYork,
USA). Demographic data were presented as the number (%)
Table 2 Number of admissions and length of hospital stay before and after the programme (n Z 185).
1 year before programme 1 year after programme Mean difference p-value
Number of admissions 2.39  2.05 1.65  2.1 0.75  2.11 (Y 31.2%) <0.001
Length of stay (days) 12.17  9.14 9.09  12.1 3.09  12.1 (Y 25.4%) <0.001
6 months before programme 6 months after programme Mean difference p-value
Number of admissions 1.79  1.23 0.96  1.42 0.83  1.35 (Y 46.4%) <0.001
Length of stay (days) 9.70  6.96 5.26  8.70 4.44  8.95 (Y 45.7%) <0.001
1774 F.W.S. Ko et al.or mean  standard deviation(SD). Comparison of the pre-
and post programme parameters including the length of
hospital stay and number of admissions were analysed using
the two-tailed Student’s t-test, and for non-normally
distributed data the non-parametric Wilcoxon signed rank
test was used. P value of <0.05 was considered as statis-
tically significant.Results
The demographic characteristics of our subjects are shown
in Table 1. There were altogether 224 subjects who had
joined our programme. Eight subjects passed away before
the first doctor’s follow up and 24 refused to return for
follow up. The age and sex of those subjects who refused to
return for follow up were similar to the subjects who
returned for follow up. In the first doctor’s follow up, 3
refused spirometry examination and 4 did not have
obstructive pattern on spirometry. We had thus included
the 185 subjects who attended the first doctor clinic follow
up with spirometry confirmed COPD in this analysis. Our
patients were mostly male with a mean FEV1 of
43.2  20.2% predicted normal. Forty (21.6%) of these pa-
tients required NPPV support in the recruitment admission.
All of the 185 subjects included in the analysis had
agreed to have nurse follow up by phone calls and returned
to nurse and doctor’s clinics. 125 patients agreed to have
assessment by physiotherapists and these subjects all had
attended at least 1 session (2 h) of out-patient physio-
therapy training and learned about home exercise. Only 32
subjects agreed for a prolonged course of out-patient ex-
ercise training whereas 20 subjects could complete 80% or
more of the 3-month (3 times a week) exercise training
programme. Only 3 patients agreed for home physiothera-
pist visits and 2 agreed for visits by community nurse. Ten
and 31 patients died at 6 months and 12 months afterTable 3 Number of admissions and length of hospital stay befo
died after recruitment into the programme (n Z 154 in 1 year, n
1 year before programme 1 yea
Number of admissions 2.15  1.91 1.54
Length of stay (days) 10.8  8.1 8.20
6 months before programme 6 mo
Number of admissions 1.76  1.21 0.89
Length of stay (days) 9.41  6.49 4.72recruitment into the programme, respectively. The number
of subjects that had participated different components of
the comprehensive programme is shown in Supplementary
Table 1.
Table 2 shows the number of hospitalizations and length
of hospital stay before and after 6 and 12 months of the
programme. At both 6 months and 12 months after joining
the programme, the number of hospitalizations and length
of hospital remained lower than before joining the pro-
gramme and the reduction had reached statistical signifi-
cance (hospitalizations for AECOPD 6 month before and
after the programme were 1.79  1.23 vs 0.96  1.42 times,
p  0.001; length of hospital stay for AECOPD 6 month
before and after the programme were 9.70  6.96 vs
5.26  8.70days, p  0.001; hospitalizations for AECOPD 12
months before and after the programme were 2.39  0.05
vs 1.65  2.1.times, p  0.001; length of hospital stay for
AECOPD 12 months before and after the programme were
12.17  9.14 vs 9.09  12.1 days, p  0.001). We also
performed analysis comparing if patients with different age
groups, baseline lung function, MMRC score, 6 min walk test
distance and SGRQ score would have any impact on their
readmissions and length of hospital stay before and after
the programme. We found that their outcomes were not
affected by the above factors (Supplementary Table 2).
Even after excluding those cases that had deceased in
the calculation of hospitalizations and length of stay for
AECOPD, the reduction of the hospitalizations and length of
hospital stay for AECOPD remained significant at 6 and 12
months (Table 3).
We also assessed the patients’ FEV1, 6 min walk test,
MMRC score and SGRQ score at the doctor’s clinic at 6 and
16 weeks post recruitment to the programme (Table 4).
Comparing these parameters at week 16 vs week 6, patients
had significant improvement in the post-bronchodilator FVC
(1.77  0.63 vs 1.83  0.66, pZ 0.04). The MMRC and SGRQ
score remained unchanged during these time points.re and after the programme, after excluding all subjects who
Z 175 in 6 months).
r after programme Mean difference p-value
 2.11 0.61  1.97 (Y 28.4%) <0.001
 11.94 2.60  11.1 (Y 24.1%) <0.001
nths after programme Mean difference p-value
 1.35 0.87  1.35 (Y 49.4%) <0.001
 8.2 4.69  8.82 (Y 49.8%) <0.001
Table 4 Comparison of the lung function, quality of life, exercise capacity, dyspnoea score of patients at 6 weeks and 16
weeks after joining the programme.
N 6-week 16-week p-value
Pre-bronchodilator FEV1 (L) 167 0.86  0.37 0.88  0.37 0.11
FVC (L) 1.71  0.62 1.77  0.64 0.04
FEV1 % predicted normal 44.6  20.0 45.4  18.8 0.21
FVC % predicted normal 62.6  21.1 64.5  20.2 0.10
FEV1/FVC ratio (%) 50.9  13.2 50.5  13.6 0.61
Post-bronchodilator FEV1 (L) 167 0.89  0.38 0.9  0.38 0.31
FVC (L) 1.77  0.63 1.83  0.66 0.04
FEV1 % predicted normal 46.0  20.4 46.4  19.3 0.49
FVC % predicted normal 64.8  21.4 66.5  20.8 0.11
FEV1/FVC ratio (%) 50.5  12.6 49.9  13.3 0.49
6 min walk test (m) 172 205  128 208  127 0.29
mMRC 168 2.43  1.01 2.38  1.00 0.42
SGRQ Symptoms 164 54.6  18.4 58.0  17.3 0.05
Activities 56.8  30.3 55.1  31.1 0.60
Impacts 34.9  28.6 35.1  26.7 0.85
Total score 44.8  25.3 45.0  24.3 0.90
Data are presented as mean  SD.
mMRC Z modified Medical Research Council questionnaire; SGRQZ St George’s Respiratory Questionnaire.
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This study has shown that a comprehensive COPD pro-
gramme consisting of input from respiratory physicians,
nurses and physiotherapists that involved optimization of
COPD drug treatment, management of comorbidities (data
not shown), patient education, telephone call by nurses,
telephone hotline for advice, and physiotherapy training,
was effective in decreasing hospital readmissions and
length of hospital stay among the enrolled subjects with
COPD in comparisons to 1 year before joining the
programme.
Since this was a multi-disciplinary programme, we could
not differentiate which component had made the pro-
gramme a success. A previous meta-analysis found that
implementation of the chronic care model for COPD had no
effect on symptoms, quality of life, lung function, and
functional status, but could decrease emergency/un-
scheduled visits and hospitalizations for the group that
received at least 2 chronic care model components [7]. Our
results concur with the finding in this meta-analysis. The
interventions in this meta-analysis were categorized into
several components: self-management, delivery system
design, decision support and clinical information system
[7]. Our programme had provided all of these components,
including education (part of self-management as defined in
the meta-analysis), “advanced access” to medical care
through our telephone hotline and fast tract clinics (de-
livery system design), guideline based pharmacotherapy for
treatment of COPD (decision support) and nurse call for
providing support (clinical information system). A recent
meta-analysis on integrated programme that included in-
terventions consisting of multidisciplinary team (two or
more health care providers) and multi-treatment (two or
more components) with a duration of at least three months
found that this type of programme not only improved
disease-specific quality of life and exercise capacity, butalso reduced hospital admissions and hospital days per
person [8].
Previous studies on self-management showed conflicting
results in decreasing AECOPD and hospitalizations [18,19].
A programme that involved patient education, stock of
steroid and antibiotic with action plan, together with case
manager follow up and patient’s phone call to case man-
agers as needed was able to decrease hospitalizations [18].
Another programme by Monninkhof et al. consisting of pa-
tient education, stock of steroid and antibiotic with action
plan, and exercise programme but no case manager follow
up/phone calls [19] found that the intervention group re-
ported more exacerbations than the control group. How-
ever, this study did not assess readmissions for AECOPD and
could not demonstrate benefits in quality of life and
symptoms. Another study by Rice et al. involving patients
receiving a single 1- to 1.5-h education session, an action
plan for self-treatment of exacerbations, and monthly
follow-up calls from a case manager for 1 year was able to
reduce hospitalizations and emergency department visits
for COPD [20]. In our study, we did not include a written
action plan or prescription of any stock of antibiotic and
prednisolone to patients for self-administration when the
patient experienced increasing symptoms or exacerbation.
Instead we offered education, a telephone hotline and
access to fast track clinic. Education for self-management
of exacerbations included use of bronchodilator, relaxed
breathing, reduced physical exertion and calling our nurses
for opinions. The diversity of components in different pro-
grammes makes direct comparisons difficult. It appears
that contact with nurses/case managers plays an important
role in decreasing recurrent COPD admissions. A previous
study of patients discharged from hospital with AECOPD
with an intermediate care package incorporating pulmo-
nary rehabilitation, self-management education and the
receipt of a written COPD action plan, together with reg-
ular nurse contact, demonstrated a reduced need for
1776 F.W.S. Ko et al.unscheduled primary care consultations and a reduction in
deaths due to COPD but did not affect the hospital read-
mission rate [21]. Another study on a nurse-led 24-h hotline
for patients found that this strategy could reduce hospital
presentations with AECOPD [22].
Optimization of drug treatment might have played an
important role in our programme. Many of our patients
were not receiving long-acting anti-cholinergics at their
baseline visits and we optimized their therapy by adding
tiotropium. A previous study has shown that tiotropium, in
comparisons to placebo, could provide benefit over sus-
tained improvement in lung function, reductions in exac-
erbations and risk of exacerbation-related hospitalizations,
and improvement in health status [23]. About 50% of our
patients were not taking long-acting beta agonist (LABA) in
the baseline visit and as these patients just had an episode
of AECOPD. LABA and inhaled steroid (ICS) combination
added in a large scale study has shown that combination
LABA and ICS can decrease COPD exacerbations, but not
mortality [24].
In our study, only a minority agreed for a formal out-
patient exercise programme whereas most had agreed to
return for assessment and be instructed to perform unsu-
pervised exercise at home. Previous studies have shown
that the acceptability of pulmonary rehabilitation was a
major concern whereas feasibility of attending was an issue
for some [25,26]. Our programme offered home physio-
therapy and home visits by physiotherapists, but many
declined due to the cost concerned. Out-patient pro-
gramme involving multiple sessions was not well accepted
by the majority of our patients. Most patients refused home
visits by community nurses in our programme due to both
the cost and doubt over its effectiveness. A previous study
in Hong Kong found that intensive community nurse-led
discharge programme could not prevent hospital read-
missions in older patients with chronic lung disease [27].
A multicenter randomized control trial (RCT) of
comprehensive care management program aiming at
reducing the risk for COPD hospitalization was terminated
because of excess mortality in the intervention group [12].
In addition, this programme involving patients with severe
COPD had not decreased COPD-related hospitalizations
[12]. The mortality rate was 13.3% in the intervention group
versus 4.6% in the control group with a mean follow up of
250 days. Our mortality rate was high at 8.8% at 6 months
and 21.1% at 12 months. Our study probably involved older
and sicker patients than the study by Fan et al. In addition,
our mean number of admissions in the 12 months prior to
the recruitment was 2.5, with 21.6% requiring NPPV support
during the recruitment admission. Previous studies on pa-
tients with COPD revealed high mortality among those with
recurrent admissions and in particular admissions with
respiratory failure requiring NPPV support [28] After
excluding those subjects who had died in the follow up
period, the patients who were alive at 12 months still had
less hospital admissions/length of hospital stay than 1 year
before the programme, suggesting the COPD programme
was effective in decreasing recurrent admissions for
AECOPD.
COPD management programme applied in different
settings and patient groups may also have different results.
A Canadian self-management programme “Living well withCOPD.” involving education, exercise programme and
managed by respiratory specialist appears to reduce hos-
pital utilization in a group of Canadian COPD patients [5].
However, a similar programme with less intensive educa-
tion and no exercise training managed by primary care
physicians in a group of Dutch patients was unable to show
long term benefits in terms of quality of life or self-efficacy
[29]. An intensive education component with exercise
training component may be important to achieve
improvement in clinical outcomes. However, a recent RCT
found that adding an educational component to a pulmo-
nary rehabilitation exercise programme could not improve
the exercise capacity, quality of life and health care usage
[30]. We suggest every programme must be audited for
their efficacy.
There are several limitations in this study. This was not a
RCT and there were no controls for comparisons. In addi-
tion, we did not compare the baseline characteristics of the
subjects for those subjects who joined and those who did
not join the programme. Change in meterological factors,
influenza seasions, occupancy level of wards might also
affect hospitalization rate and length of stay. However, the
promising result of this programme reflected a “real-life
field setting”, with a 28.4% decrease in the number of
readmissions and 24.1% reduction in length of hospital stay
1 year after the programme. This study not only contrib-
uted by filling in some gap in the knowledge about a
comprehensive programme in a real life setting, but also
provided more information on the effect of a comprehen-
sive programme on a group of relatively more severe COPD
patients. As this was a multi-disciplinary service pro-
gramme, we were unable to identify which components had
contributed more to the reduction in readmissions for
AECOPD. The optimization of medications (change of
medication in 66.5% of our patients in the first doctor’s
visit), education by our nurses (received by all our sub-
jects), optimization of management of comorbidities at the
doctor’s clinic probably all played significant roles in
decreasing readmissions for AECOPD in our group of
patients.
In conclusion, this study has shown that a multi-
disciplinary COPD service programme could reduce hospi-
tal admissions and length of hospital stay. Further RCTs are
needed to provide a more accurate assessment of the
relative importance of the individual components of COPD
programme packages and the effectiveness of the pro-
gramme through objective measurements, including read-
mission rates, quality of life and exercise capacity.Conflict of interest
All authors have no conflict of interest to declare.Summary at a glance
Multi-disciplinary COPD service programme (including COPD
clinic by respiratory physicians, COPD education and nurse
clinics by respiratory nurses, out-patient pulmonary reha-
bilitation programme by physiotherapists, fast track doc-
tor’s clinic, telephone hotline for patients and nurse
COPD programme reduces hospitalization 1777telephone calls to patients) could lead to reduction in
hospital admissions and length of hospital stay.
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